Skip to main content
. 2023 May 25;9(2):e12385. doi: 10.1002/trc2.12385

FIGURE 3.

FIGURE 3

Mechanisms of action of agents in Phase 2. APOE, apolipoprotein E; DMT, disease‐modifying therapy. (Figure © J Cummings; M de la Flor, PhD, Illustrator).